Thermo Fisher Scientific
TMO
1,246 hedge funds and large institutions have $67.1B invested in Thermo Fisher Scientific in 2017 Q4 according to their latest regulatory filings, with 150 funds opening new positions, 427 increasing their positions, 489 reducing their positions, and 57 closing their positions.
163% more first-time investments, than exits
New positions opened: 150 | Existing positions closed: 57
7% more funds holding
Funds holding: 1,162 → 1,246 (+84)
1% more capital invested
Capital invested by funds: $66.4B → $67.1B (+$763M)
0.55% more ownership
Funds ownership: 87.62% → 88.17% (+0.55%)
9% less funds holding in top 10
Funds holding in top 10: 98 → 89 (-9)
13% less repeat investments, than reductions
Existing positions increased: 427 | Existing positions reduced: 489
47% less call options, than puts
Call options by funds: $151M | Put options by funds: $286M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$464M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
+$210M |
| 3 |
Nordea Investment Management
Stockholm,
Sweden
|
+$197M |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
+$156M |
| 5 |
JP Morgan Chase
New York
|
+$129M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$205M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$168M |
| 3 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$143M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$114M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$106M |
TMO Hedge Fund Activity: Q4 2017 in Review
1,246 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q4 2017, worth a combined $67.1B — up 1.1% from $66.4B a quarter earlier.
Buyers outnumbered sellers: 150 funds opened new TMO positions and 57 closed out — a net gain of 93 holders — while 427 added to existing stakes and 489 trimmed.
The largest buyer was Baillie Gifford & Co, opening a new position worth an estimated $464M. The largest seller was Ameriprise, cutting an estimated $205M.
- 1,246 institutional investors held Thermo Fisher Scientific (TMO) as of Q4 2017, up from 1,162 in Q3 2017.
- Funds reported $67.1B of Thermo Fisher Scientific stock for Q4 2017, up 1.1% quarter-over-quarter.
- 150 funds opened new Thermo Fisher Scientific positions in Q4 2017 and 57 closed out, a net change of +93 holders.
- The largest Thermo Fisher Scientific buyer in Q4 2017 was Baillie Gifford & Co, an estimated $464M added.
- The largest Thermo Fisher Scientific seller in Q4 2017 was Ameriprise, an estimated $205M sold.
Based on aggregated 13F filings for Q4 2017.